Bausch Health Companies Inc.
BHC· NYSE
Released Feb 21, 2024, after the close
10-K filed Feb 22, 2024, 53 days after period end · 0000885590-24-000011
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020 |
|---|---|---|---|---|
| Revenue | $2.41B | $2.19B | $2.20B | $2.21B |
| Net Income | -$39.00M | -$410.00M |
Bausch Health Companies Inc. · CIK 885590 · Engraved from SEC EDGAR
| $69.00M |
| -$153.00M |
| EPS Diluted | — | — | — | -$0.43 |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.